LSD1 demethylase inhibition prevents cardiac fibrosis in both ischemic and congenital diseases in mice and pig models DOI Open Access

D Arnaud,

V. Lambert,

David Benoîst

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Дек. 11, 2024

ABSTRACT Fibrosis is part of a clinical burden in cardiovascular diseases. The pathological process has been the subject intensive research with still mitigated therapeutic options. Recently chromatin modifiers have turned out to be potential drugs modulate fibrosis. Here, order address question pharmacological inhibition fibrosis, we used both mouse model myocardial infarction left ventricular fibrosis and more clinically relevant pig right failure featuring interstitial Treatment these diseased animal models an inhibitor Lysine Demethylase 1 (LSD1) significantly prevented pig, respectively. This was revealed by significant recovery function post-myocardial limitation remodeling ventricle, thus preserving its function. decreased hearts, which likely account for improvement We provide evidence beneficial effect LSD1 inhibitors cardiac use such preserve ischemic congenital heart NEW & NOTEWORTHY Drugs prevent limited outcomes. work inspired oncology, provides that epigenetic modifier targets epithelial-to-mesenchymal transition turns efficient non-ischemic

Язык: Английский

Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis DOI Creative Commons
Cong Chen, Jie Wang,

Shan Zhang

и другие.

Redox Biology, Год журнала: 2024, Номер 76, С. 103321 - 103321

Опубликована: Авг. 19, 2024

Cell death constitutes a critical component of the pathophysiology cardiovascular diseases. A growing array non-apoptotic forms regulated cell (RCD)-such as necroptosis, ferroptosis, pyroptosis, and cuproptosis-has been identified is intimately linked to various conditions. These RCD are governed by genetically programmed mechanisms within cell, with epigenetic modifications being common crucial regulatory method. Such include DNA methylation, RNA histone acetylation, non-coding RNAs. This review recaps roles modifications, RNAs in diseases, well which regulate key proteins involved death. Furthermore, we systematically catalog existing pharmacological agents targeting novel their action article aims underscore pivotal role precisely regulating specific pathways thus offering potential new therapeutic avenues that may prove more effective safer than traditional treatments.

Язык: Английский

Процитировано

7

m6A control programmed cell death in cardiac fibrosis DOI
Zhenyu Liu,

Qing-Ye You,

Zhiyan Liu

и другие.

Life Sciences, Год журнала: 2024, Номер 353, С. 122922 - 122922

Опубликована: Июль 18, 2024

Язык: Английский

Процитировано

5

RNA and epigenetic editing: The new frontier in gene and cell therapy DOI
Federico Ávila‐Moreno, Paloma H. Giangrande

Molecular Therapy, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Novel Epitranscriptomic and Epigenetic Therapeutic Strategies and Targets for Ferroptosis in Liver Fibrosis DOI
Minghui Li, Yang Yang,

Qi-Qi Dong

и другие.

European Journal of Pharmacology, Год журнала: 2025, Номер 996, С. 177344 - 177344

Опубликована: Фев. 25, 2025

Язык: Английский

Процитировано

0

The epigenetic regulation of crosstalk between cardiac fibroblasts and other cardiac cell types during stress DOI Creative Commons
Lindsay Kraus,

Salim Fredericks,

Katelyn Scheeler

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2025, Номер 12

Опубликована: Апрель 8, 2025

With the global impact of cardiovascular disease, there is a dire need to understand mechanisms in heart during injury and stress. It has been shown that regulation extracellular matrix via cardiac fibroblasts plays major role progression failure worsening function heart. Importantly, it suggested crosstalk between other cells like cardiomyocytes, immune cells, endothelial are influenced by pathological fibroblasts. This decline across all seemingly irreversible. However, epigenetic have regulate functionality improve outcomes stress or injury. also control communication different cell types influence multiple The goal this review summarize discuss current research subsequent with disease states.

Язык: Английский

Процитировано

0

Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m6A modification in atherosclerosis DOI Creative Commons

Xiaorui Ping,

Xiaoyun Liang,

Wenlu Xing

и другие.

Theranostics, Год журнала: 2025, Номер 15(10), С. 4785 - 4807

Опубликована: Март 29, 2025

Background: Atherosclerosis is a chronic inflammatory disease that the major cause of mortality worldwide. Although several studies have assessed function m6A (N6-methyladenosine) modification in atherosclerosis, its regulatory mechanism at single-cell level remains unclear. This study provides comprehensive atlas regulating cell-type-specific functions atherosclerosis. Methods: We analyzed sequencing data derived from atherosclerosis patients to elucidate influence on diverse cell types. demonstrated potential regulators across various types and key transcription factors involved. Furthermore, we discovered mediated intercellular communication important biological processes. In vitro experiments were conducted further investigate effects ALKBH5, WTAP METTL3 Results: ALKBH5 upregulated endothelial cells induced proliferation migration involved sprouting angiogenesis. smooth muscle cells, upregulation enhanced proliferation, phenotypic transformation. Upregulation YTHDF2 promoted macrophage activation differentiation. identified abnormally activated could regulate manner. Moreover, revealed implicated dysregulated And series experimental validations supported conclusion exert functions. Conclusion: Our provided evidence for roles orchestrating atherosclerotic functions, representing promising targets precision medicine.

Язык: Английский

Процитировано

0

Role of M6a Methylation in Myocardial Ischemia–Reperfusion Injury and Doxorubicin-Induced Cardiotoxicity DOI
Yanfang Liu, Hui Wu, Gang Zhou

и другие.

Cardiovascular Toxicology, Год журнала: 2024, Номер 24(9), С. 918 - 928

Опубликована: Июль 18, 2024

Язык: Английский

Процитировано

3

METTL14 depletion induces trophoblast cell dysfunction by inhibiting miR–21-5p processing in an m6A-dependent manner DOI
Xiaoli Qin,

Xiaona Huo,

Junpeng Dong

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 142, С. 113200 - 113200

Опубликована: Сен. 27, 2024

Язык: Английский

Процитировано

1

N6-Methyladenosine-mediated phase separation suppresses NOTCH1 expression and promotes mitochondrial fission in diabetic cardiac fibrosis DOI Creative Commons
Zhiyan Liu,

Li-Chan Lin,

Zhenyu Liu

и другие.

Cardiovascular Diabetology, Год журнала: 2024, Номер 23(1)

Опубликована: Сен. 28, 2024

Язык: Английский

Процитировано

1

m6A RNA methylation: The latent string-puller in fibrosis DOI

Xinglan He,

Bingsi Tang,

Puyu Zou

и другие.

Life Sciences, Год журнала: 2024, Номер 346, С. 122644 - 122644

Опубликована: Апрель 16, 2024

Язык: Английский

Процитировано

0